Streetbeat News

TPST

Tempest Therapeutics, Inc.

https://www.tempesttx.com

Industry

Biotechnology

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.

Open

0.84

Mkt cap

37M

Volume

473K

High

0.85

P/E Ratio

-0.55

52-wk high

6.00

Low

0.82

Div yield

N/A

52-wk low

0.70

On Tuesday, 132 companies hit new 52-week lows. Among them, Corning (NYSE:GLW) was the largest in terms of market cap, while Wheeler Real Estate IT (NASDAQ:WHLR) was the smallest. Fortress Biotech (NASDAQ:FBIO) saw the largest move with shares plummeting 1350.03%, while Insulet (NASDAQ:PODD) made the biggest bounce back, moving up 0.0% shortly after hitting a new 52-week low.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 5:09 pm

Several stocks are experiencing significant pre-market movements. Immunic, Inc. (NASDAQ:IMUX) shares gained 13.2% after positive interim data from a Phase 2 trial. SuperCom Ltd. (NASDAQ:SPCB), Tempest Therapeutics, Inc. (NASDAQ:TPST), Mobilicom Limited (NASDAQ:MOB), SMX (Security Matters) Public Limited Company (NASDAQ:SMX), ContraFect Corporation (NASDAQ:CFRX), and ParaZero Technologies Ltd. (NASDAQ:PRZO) also saw pre-market gains. On the other hand, Borqs Technologies, Inc. (NASDAQ:BRQS), Phoenix Motor Inc. (NASDAQ:PEV), Atreca, Inc. (NASDAQ:BCEL), RVL Pharmaceuticals plc (NASDAQ:RVLP), Molekule Group, Inc. (NASDAQ:MKUL), Windtree Therapeutics, Inc. (NASDAQ:WINT), Applied UV, Inc. (NASDAQ:AUVI), Vascular Biogenics Ltd. (NASDAQ:VBLT), Maison Solutions Inc. (NASDAQ:MSS), and Future FinTech Group Inc. (NASDAQ:FTFT) experienced pre-market losses.

Portfolio Pulse from Lisa Levin

October 10, 2023 | 12:20 pm

In Monday's after-market session, several healthcare stocks saw significant movement. Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares rose by 536.4%, while Avinger (NASDAQ:AVGR) shares increased by 49.42%. Elutia (NASDAQ:ELUT), Aclarion (NASDAQ:ACON), Singular Genomics Sys (NASDAQ:OMIC), and Stereotaxis (AMEX:STXS) also saw increases. On the other hand, Kinnate Biopharma (NASDAQ:KNTE), T2 Biosystems (NASDAQ:TTOO), Redhill Biopharma (NASDAQ:RDHL), Perspective Therapeutics (AMEX:CATX), Tempest Therapeutics (NASDAQ:TPST), and CohBar (NASDAQ:CWBR) saw decreases in their share prices.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 9:31 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. Senti Biosciences, MSP Recovery, HCW Biologics, Tempest Therapeutics, TransCode Therapeutics, and Nemaura Medical saw increases in their share prices, while Avalo Therapeutics, Axcella Health, Eiger BioPharmaceuticals, ENDRA Life Sciences, Jin Medical International, and Synlogic experienced decreases.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 9:31 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Biocept (BIOC), Axcella Health (AXLA), Myomo (MYO), Lucy Scientific Discovery (LSDI), Atossa Therapeutics (ATOS), and Aesthetic Medical Intl (AIH) saw their shares rise, with Biocept leading the gainers with a 59.4% increase. On the other hand, Plus Therapeutics (PSTV), NeuBase Therapeutics (NBSE), Ekso Bionics Holdings (EKSO), Allarity Therapeutics (ALLR), Trevena (TRVN), and Tempest Therapeutics (TPST) saw their shares decline, with Plus Therapeutics leading the losers with a 29.3% decrease.

Portfolio Pulse from Benzinga Insights

September 08, 2023 | 5:31 pm

Tempest Therapeutics announced that Tom Dubensky has resigned as President and Board Member, effective from September 2, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 8:24 pm

Healthcare stocks showed significant movement in Wednesday's after-market session. Artelo Biosciences, Corvus Pharma, Biodexa Pharmaceuticals, SeaStar Medical Holding, Impel Pharmaceuticals, and Hyperfine saw gains, while BioRestorative Therapies, NeuBase Therapeutics, Tempest Therapeutics, PaxMedica, Palisade Bio, and Phreesia experienced losses. Phreesia's drop followed the release of its Q2 earnings.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 9:31 pm

On Wednesday, 179 companies reached new 52-week lows. Pfizer (NYSE:PFE) was the largest company to set a new 52-week low, while Gaucho Group Holdings (NASDAQ:VINO) was the smallest. EZGO Technologies (NASDAQ:EZGO)'s stock fell the most, dropping 78.43% to reach a new 52-week low. Protara Therapeutics (NASDAQ:TARA)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 6:43 pm

In Monday's after-market session, several healthcare stocks saw significant movement. Bionomics (BNOX), Tempest Therapeutics (TPST), Sunshine Biopharma (SBFM), Lucy Scientific Discovery (LSDI), Societal CDMO (SCTL), and Celularity (CELU) saw their stocks rise, while Orgenesis (ORGS), SCWorx (WORX), Reshape Lifesciences (RSLS), Rain Oncology (RAIN), PaxMedica (PXMD), and TFF Pharmaceuticals (TFFP) saw their stocks fall.

Portfolio Pulse from Benzinga Insights

August 28, 2023 | 9:31 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Gainers included Novo Integrated Sciences (NVOS), Nexalin Technology (NXL), T2 Biosystems (TTOO), MSP Recovery (LIFW), Alzamend Neuro (ALZN), and Tenon Medical (TNON). Losers included Impel Pharmaceuticals (IMPL), Tempest Therapeutics (TPST), Eloxx Pharmaceuticals (ELOX), Aeglea BioTherapeutics (AGLE), Kezar Life Sciences (KZR), and Cingulate (CING). Several companies recently released their Q2 earnings reports.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 9:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.